PMI wins EU trademark appeal over ‘Sienna’ vapes
10-06-2021
Belgian brewer beats gambling brand at General Court
10-09-2020
EU General Court backs Scor in insurance TM dispute
08-07-2020
General Court hands TM win to Off-White
26-06-2020
09-09-2020
GlaxoSmithKline (GSK) can’t register a shade of purple as a trademark covering asthma inhalers, the EU General Court has ruled.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
GSK, GlaxoSmithKline, EU General Court, purple, colour, EUIPO, Seretide, asthma, inhaler